Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | 2,537 | 1,316 | 507 | 0 |
| Gross Profit | 2,537 | 1,316 | 507 | N/A |
| Operating Expenses | 5,436 | 5,263 | 4,962 | 0 |
| Operating Income | -2,899 | -3,947 | -4,455 | N/A |
| Interest Expense | 202 | 216 | 234 | 0 |
| Other Income | 23 | -105 | 0 | 0 |
| Pre-tax Income | -3,078 | -4,268 | -4,689 | 0 |
| Net Income Continuous | -3,078 | -4,268 | -4,689 | N/A |
| Net Income | $-3,078 | $-4,268 | $-4,689 | $N/A |
| EPS Basic Total Ops | -192.60 | -268.40 | -10.40 | N/A |
| EPS Basic Continuous Ops | -192.38 | -268.43 | -10.49 | N/A |
| EPS Diluted Total Ops | -192.60 | -268.40 | -10.40 | N/A |
| EPS Diluted Continuous Ops | -192.38 | -268.43 | -10.49 | N/A |
| EBITDA(a) | $-2,785 | $-3,812 | $-4,317 | $N/A |